ArticleAdvances in therapy2026

Real-World Risk of Myelodysplastic Syndrome/Acute Myeloid Leukemia and Other Second Primary Malignancies in Patients with Epithelial Ovarian Cancer Treated with Niraparib Maintenance Therapy: Results from a Postauthorization Safety Study.

Maurice J D L van der Vorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.